Leptospirosis has long been a sneaky threat lurking in the shadows of canine health, but recent shifts in our understanding are turning heads—and saving lives. Imagine a disease that can strike any dog, urban or rural, leading to devastating kidney failure or worse. That's the reality we're facing, and the 2023 ACVIM update is reshaping how we tackle it. Stick around to uncover what this means for your practice and pet owners everywhere—it's not just about vaccines; it's about proactive prevention in a changing world.
But here's where it gets controversial: The guidelines are pushing for universal annual vaccination against leptospirosis, even though it was once seen as a 'non-core' vaccine. Is this a necessary evolution to protect all dogs, or is it overkill that could burden owners and vets alike? We'll explore that tension as we break down the key takeaways from expert Jane Sykes, BVSc, PhD, MPH, MBA, FNAP, who distilled the practical essentials from the 2023 ACVIM consensus update. She sheds light on the major shifts, how to reassure worried pet parents, when to run tests, and safe clinic protocols for suspected cases. Plus, we'll dive into updated diagnostics that are making diagnosis faster and more accurate—yet not without their nuances.
This dvm360 Q&A has been carefully edited and streamlined from a lively verbal chat to fit a written piece, keeping the heart of the discussion intact while enhancing clarity for everyone, from seasoned vets to those just starting out.
What's the most crucial takeaway from the consensus statement that every general practitioner should prioritize?
Sykes emphasizes that our evolving grasp of leptospirosis epidemiology, testing methods, and vaccine tech has flipped the script. This bacterial infection, spread through contaminated water or contact with infected animals' urine, isn't confined to farm dogs anymore—urban areas are seeing more cases too. With newer vaccines boasting improved safety profiles and solid data on lasting protection (often a year or more), the update now recommends annual leptospirosis shots for every canine. That's a big pivot from its previous non-core status, meaning it's now a standard part of routine care to shield against this potentially deadly illness that can cause kidney damage, liver issues, and even death.
How can vets address owners' concerns about vaccine safety and benefits in an approachable way?
Sykes suggests weaving in relatable narratives to make it personal. Highlight how vaccines have advanced significantly, now matching the safety of staples like distemper, hepatitis, and parvovirus shots. Share real-world examples: Most leptospirosis cases we encounter involve dogs that skipped or missed vaccinations, leading to grim outcomes. Stress the stakes—untreated, it can be fatal, with veterinary bills soaring into the thousands as treatments might include intensive care or dialysis. If a client opts out, be sure to note their choice in the medical records for future reference, keeping transparency at the forefront.
When is the right time for a GP to order leptospirosis testing?
Sykes advises testing when dogs show matching symptoms, particularly signs of sudden kidney problems after the initial 24 to 48 hours of feeling unwell. Early on, leptospirosis might mimic a vague feverish illness, making it tricky to spot. Kidney issues often emerge in those first couple of days, sometimes paired with liver complications—but the kidney angle is key. Factor in vaccination status too; properly vaccinated pups are far less susceptible, and recent shots can skew antibody tests. For beginners, think of it like this: If a dog has been lethargic, vomiting, or showing dark urine (a hint at kidney strain), and it's not responding to basic care, leptospirosis could be the culprit—test to confirm and rule out.
What's the step-by-step protocol for managing a suspected leptospirosis case in your clinic?
Sykes outlines a practical approach focused on prudent precautions over full quarantine. The peak transmission risk lasts during the first 48 hours of antibiotic treatment, so gear up with waterproof gowns, gloves, and facial shields, and handle urine and waste meticulously. Encourage outdoor urination on a portable setup like a gurney to prevent clinic messes. If spills occur indoors, grab a reliable disinfectant as per its label—no need for harsh chemicals like bleach every time. Importantly, expectant staff should steer clear of direct interaction. Once those initial 48 hours pass with proper meds, transmission drops dramatically, allowing relaxed handling while still exercising common sense.
Key leptospirosis action points for vets:
Align with the latest consensus by giving annual leptospirosis vaccines to all dogs, promoting broad protection against this adaptable pathogen.
Screen for the disease in pets displaying compatible symptoms plus acute kidney indicators, especially after 24 to 48 hours of sickness—early detection can be life-saving.
Implement protective measures during the first 48 hours of antibiotics: Don impermeable gear when dealing with urine or feces, and keep pregnant team members away from hands-on duties.
Opt for PCR testing on blood and urine samples early in the process if accessible. Evaluate rapid antibody tests with an eye to timing and vaccine history, and consider follow-up antibody checks a week later to catch seroconversion (the rise in antibodies signaling active infection).
How have diagnostic tools evolved, and what's the best way to interpret point-of-care tests?
Sykes points out exciting advancements with in-clinic antibody tests now available in the US, like the IDEXX SNAP Lepto (which spots both IgG and IgM antibodies) and the Zoetis Witness Lepto (focusing on IgM only). These are antibody-based, so they might come up negative in the disease's first week while the immune system ramps up its response. A negative result early on doesn't eliminate leptospirosis—re-test after a week to possibly see that telltale antibody shift. Remember, past vaccinations or hidden exposures can trigger positives too; studies show 10% or more of healthy dogs might test positive. For a clearer picture, an IgM-specific test like Witness is less prone to false positives from old exposures, and a positive in a symptomatic dog with kidney woes strongly points toward leptospirosis. And this is the part most people miss: These tests aren't foolproof alone—they're tools to guide, not dictate, decisions.
What role do PCR and MAT play in the diagnostic mix?
Sykes notes a growing reliance on PCR for blood and urine samples, which proved invaluable during a Los Angeles outbreak by confirming infections in most cases when both were used. Meanwhile, the microscopic agglutination test (MAT) stands as the top serologic benchmark, though it's hands-on and often done retrospectively by specialists, requiring paired samples and potentially delayed results due to batch processing. To clarify for newcomers, MAT essentially measures how well antibodies clump bacteria in a lab dish, offering a detailed view of exposure levels. The strategy? Lean on PCR right away for its speed, and always contextualize antibody results with vaccine timelines to avoid misreads.
Do you have a passionate stance or final thoughts on leptospirosis that you'd like to share?
Sykes passionately champions vaccinating every dog, driven by the brutal reality of leptospirosis: It inflicts severe health crises, sometimes necessitating dialysis, with costs ballooning to tens of thousands. Her unwavering commitment is to thwart this through widespread vaccination, preventing needless suffering.
For more updates and expert takes from Fetch Long Beach, check out dvm360’s special conference hub at https://www.dvm360.com/conference/fetch-long-beach.
Stay in the loop with exam room hacks, practice tips, and the latest in vet news—sign up for the dvm360 newsletter to get it delivered right to your inbox.
Now, let's spark some discussion: With leptospirosis cases on the rise in unexpected places, do you agree that annual vaccination for all dogs is the proactive path forward, or does it feel like an unnecessary expansion of protocols? Could targeting high-risk groups based on lifestyle or location be a smarter, more nuanced approach? Share your experiences, agreements, or counterarguments in the comments—we'd love to hear diverse perspectives on navigating this evolving challenge!
